Deciphera Pharmaceuticals
The Vice President, US Market Access is responsible for developing and implementing strategies to ensure patient, provider, and payer access to specialized oncology therapies. The role involves leading a team, shaping market access and reimbursement strategies, and collaborating across various functions to support product value and market success.
Headquarters
Waltham, Massachusetts, United States
Company Size
201-500 employees
Founded
2003
Deciphera Pharmaceuticals, now a member of ONO Pharma, is a biopharmaceutical company dedicated to discovering, developing, and commercializing switch-control kinase inhibitors and other targeted therapies to improve outcomes for people with cancer. The company's portfolio includes approved medicines QINLOCK (ripretinib) for advanced gastrointestinal stromal tumor and ROMVIMZA (vimseltinib), as well as a broad pipeline of clinical-stage candidates such as tirabrutinib and sapablursen. Driven by a patient-inspired mission to defeat cancer, Deciphera focuses on addressing key mechanisms of tumor and drug resistance through its proprietary discovery platform.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Deciphera Pharmaceuticals.
99% above the average for this role
Market Access Manager, Oncology (Lung, Heamatology and GI)
AstraZeneca
Vice President, Market Access
Verastem
Vice President, Market Access
Mirum Pharmaceuticals
Market Access Strategy Director
BioFire Diagnostics
VP, US Market Access
BioFire Diagnostics
Market Access Manager, Oncology (Lung, Haematology and GI)
AstraZeneca